The Week in Wearables March 13

Consumer Wearables

Retrospective on Samsung’s attempt to preempt the Apple Watch with an advanced health wearable. It also highlights the difficulty of building an accurate consumer health wearable, particularly at the wrist. Here.

More on Samsung wearables plans from Samsung’s European head of product, including smartwatches, hearables, VR, and more. Here.

Interesting discussion of Fitbit’s earnings, particularly an analysis of their ongoing customer engagement. This is the first public analysis I’ve seen that quantifies the problem. Here.

Baselworld 2017 kicks off this week, which is why you saw several smartwatch announcements from traditional luxury watchmakers, including:

  • Tag Heuer announcing their second-generation smartwatch, the Tag Heuer Modular Connected 45. Internals are powered by Android Wear 2.0 and Intel. They claim every visible part of the watch can be replaced and/or customized. Here.
  • Montblanc gets into the smartwatch market with the Montblanc Summit. The only thing different here appears to be that this is the first luxury smartwatch to add a heart rate monitor, although it’s not clear why. Here.
  • Movado will launch 5 smartwatches powered by Android Wear 2.0 this fall under the Movado, Tommy Hilfiger, and Hugo Boss brands. Here.
  • Swatch is also getting into smartwatches, first with their Tissot brand, but have decided to build their own operating system targeted toward lower power, higher security than what’s available on the market today. It’s highly unlikely they’ll build a meaningful app ecosystem around their OS, but that may not matter for . Here.
  • However, you won’t see the Swarovski smartwatch at Baselworld 2017 as expected. Here.

Medical Wearables

Alivecor takes in another $30M from Omron and Mayo Clinic and launches stroke prevention platform utilizing data and learning from a 4,500 patient study on strokes. Here.

Apple’s healthcare market strategy to “look at themselves as a platform” appears to be making gains. Here.

Speaking of Apple in healthcare, here are results from a large-scale study conducted completely through mobile phones via Apple’s ResearchKit. This research sets the foundation for “longitudinal, multidimensional data (e.g., surveys, devices, geolocation, and air quality)” going forward. Here.

Roughly 80 percent of all interactions between a doctor and a patient end with at least one prescription, amounting to more than 4 billion prescriptions a year in the United States. Here.

Good summary of the health tech discussions at SXSW 2017. Here.

Reminder that health wearables design and user experience must be paired with solid behavioral psychology techniques to impact long term behavior change. Here.


The global market for remote patient monitoring devices expected to grow to nearly $2B per year by 2025 (CAGR 13.4%), from Grand View Research. Here.

More data on remote patient monitoring devices, this one from ABI Research, projecting 33M devices sold in 2021 (35% CAGR). Here.

Leave a Reply

Your email address will not be published. Required fields are marked *